EBS
Emergent Biosolutions Inc

7,323
Loading...
Loading...
News
all
press releases
Emergent BioSolutions Stock Rises After Receiving Fresh International Purchase Orders: Retail Says Stock Is ‘Significantly Undervalued’
The order encompasses multiple product offerings within Emergent’s medical countermeasures business, including countermeasures for threats posed by Smallpox, Anthrax, and Botulism.
Stocktwits·16d ago
News Placeholder
More News
News Placeholder
Emergent BioSolutions Stock Rises After New US Order For Smallpox Complication Therapy
The company also secured a $62.4 million modification to its botulism antitoxin supply contract and recently expanded its NARCANDirect platform to include a new opioid overdose reversal spray.
Stocktwits·3mo ago
News Placeholder
5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost
Zacks·4mo ago
News Placeholder
Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions
Zacks·5mo ago
News Placeholder
Emergent Biosolutions (EBS) Q1 Earnings Top Estimates
chainwire·5mo ago
News Placeholder
Emergent BioSolutions Stock Sinks As Q4 Revenue Plunges 30%, But Retail Clings To Profit Swing
For the first quarter, Emergent forecasted revenue in the range of $200 million to $240 million, lower than an analyst estimate of $279 million.
Stocktwits·7mo ago
News Placeholder
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks
Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.
Stocktwits·11mo ago
News Placeholder
10 Stocks Retailers On Stocktwits Are Most Bullish/Bearish About To Start The Week
As the new week unfolds, earnings and economic data will again dictate sentiment.
Stocktwits·11mo ago
News Placeholder
Emergent Biosolutions Stock Soars After Q3 Earnings: Retail Sentiment Strong
Earnings per share for Q3 came in at $1.37, compared to consensus estimates of $0.10.
Stocktwits·11mo ago
News Placeholder
Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024
Emergent BioSolutions stock rises on mixed Q3 results, improved 2024 guidance, and news of a new trial for mpox treatment in Africa led by the CDC. read more...
Benzinga·11mo ago

Latest EBS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.